1. Home
  2. Business & Finance
  3. Investing for Beginners
Research and Development Costs - R&D
Investing Lesson 4 - Analyzing an Income Statement
 More of this Feature

• Introduction
• Income Statement
• Revenue / sales
• Cost of Goods Sold
• Gross profit
• Gross margin
• The first three lines
• Operating Expenses
• R&D Expense
• SG&A Expense
• Goodwill Charges
• Extraordinary Events
• Accounting for extraordinary events
• Oper. income/margin
• Interest income and expense
• Interest coverage ratio
• Depreciation expense
• Accum. Depreciation
• Straight-line Method
• Accelerated and Sum of the Years' Digits Method
• Dbl Declining Balance
• Comparing Depr. Mths
• EBITDA
• Income taxes
• Minority Interests - cost, equity, and consolidated methods
• Unreported earnings
• Continuing operations
• Accounting changes
• Preferred dividends
• Net income applicable to common shares
• Net profit margin
• Basic vs. Diluted EPS
• Hiding share dilution
• Share repurchases
• Return on Equity- ROE
• Asset turnover
• Return on Assets- ROA
• Projecting earnings
• Formulas & Calculations
• Putting it together

• Segment 2

 Related Resources
• Investing Lesson 1
• Investing Lesson 2
• Investing Lesson 3
• More Lessons
 From Other Guides
•  Calculating Gross Profit
• Extraordinary Items on the Income Statement 
 Elsewhere on the Web
• Gross Profit Margin Calculator
• Gross Profit Calculator
• What is Cost of Goods Sold COGS

Research and Development
R&D costs can range from nothing to billions of dollars, depending upon the type of business you are analyzing. Unlike many other costs (such as income taxes), management is almost entirely free to decide how should be spent. In 2001, Eli Lilly, one of the world’s largest pharmaceutical companies, plowed nearly 26% of the total gross profit back into R&D.

How much should a company spend on R&D? It depends. In highly creative and fast-moving industries, the amount of money spent on the research and development budget can literally determine the future of the business. If Eli Lilly stopped funding the development of new drugs, its future profitability would suffer, causing a perhaps permanent decline in earnings. In such cases, it may be appropriate to compare the level of R&D funding to profitability over time, as well as to the percentage of gross profit competitors spend on research and development.

Next page > Selling, General and Administrative (SG&A)Expenses> << back, 8, 9, 10, 11, 12, 13, 14, more >>

Join the Money Newsletter for even more great articles and lessons!

Explore Investing for Beginners

More from About.com

  1. Home
  2. Business & Finance
  3. Investing for Beginners

©2008 About.com, a part of The New York Times Company.

All rights reserved.